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Background: We assessed the impact of diabetes mellitus on plaque vulnerability and clinical outcome in 224 acute myocardial infarction (AMI) 
patients (116 ST segment elevation and 108 non-ST segment elevation AMI, 94 diabetic and 130 non-diabetic patients) with plaque rupture (PR).
Methods: Major intravascular ultrasound (IVUS) findings included multiple ruptured plaques (different PRs separated by a >5-mm length of artery 
containing smooth lumen contours) and a thrombus. The incidences of no-reflow, stent thrombosis, and 12-month major adverse cardiac event 
(MACE) including death, MI, target vessel revascularizations were observed.
Results: The presence of multiple PR (62% vs. 31%, p<0.001) and thrombus (74% vs. 54%, p=0.002) were more common in diabetic patients 
compared with non-diabetic patients. The composite of no-reflow and acute stent thrombosis after stent implantation occurred more frequently 
in diabetic patients compared with non-diabetic patients (22% vs. 11%, p=0.019) and diabetes mellitus [odds ratio (OR): 2.968, 95% CI: 1.287-
6.542, p=0.024) and multiple PR (OR: 3.128, 95% CI: 1.357-6.687, p=0.012) were the independent predictors of the composite of no-reflow and 
acute stent thrombosis. There was no significant difference in 12-month MACE between diabetic and non-diabetic patients (17% vs. 11%, p=0.18).
Conclusions: Diabetic AMI patients with IVUS-evident PR have more plaque vulnerability (more frequent multiple PR and more thrombus) and have 
higher incidences of acute complications after stenting compared with non-diabetic AMI patients with PR.
